ICD-10-CM Codes > F10-F19 > F19

Other psychoactive substance related disorders
2025 ICD-10-CM DIAGNOSIS CODE F19

Code Attributes

  • Non-Billable/Non-Specific Code


Includes

  • Polysubstance drug use (indiscriminate drug use)

Codes


  • F19.1 Other psychoactive substance abuse
  • F19.10 Other psychoactive substance abuse, uncomplicated
  • F19.11 Other psychoactive substance abuse, in remission
  • F19.12 Other psychoactive substance abuse with intoxication
  • F19.120 Other psychoactive substance abuse with intoxication, uncomplicated
  • F19.121 Other psychoactive substance abuse with intoxication delirium
  • F19.122 Other psychoactive substance abuse with intoxication with perceptual disturbances
  • F19.129 Other psychoactive substance abuse with intoxication, unspecified
  • F19.13 Other psychoactive substance abuse with withdrawal
  • F19.130 Other psychoactive substance abuse with withdrawal, uncomplicated
  • F19.131 Other psychoactive substance abuse with withdrawal delirium
  • F19.132 Other psychoactive substance abuse with withdrawal with perceptual disturbance
  • F19.139 Other psychoactive substance abuse with withdrawal, unspecified
  • F19.14 Other psychoactive substance abuse with psychoactive substance-induced mood disorder
  • F19.15 Other psychoactive substance abuse with psychoactive substance-induced psychotic disorder
  • F19.150 Other psychoactive substance abuse with psychoactive substance-induced psychotic disorder with delusions
  • F19.151 Other psychoactive substance abuse with psychoactive substance-induced psychotic disorder with hallucinations
  • F19.159 Other psychoactive substance abuse with psychoactive substance-induced psychotic disorder, unspecified
  • F19.16 Other psychoactive substance abuse with psychoactive substance-induced persisting amnestic disorder
  • F19.17 Other psychoactive substance abuse with psychoactive substance-induced persisting dementia
  • F19.18 Other psychoactive substance abuse with other psychoactive substance-induced disorders
  • F19.180 Other psychoactive substance abuse with psychoactive substance-induced anxiety disorder
  • F19.181 Other psychoactive substance abuse with psychoactive substance-induced sexual dysfunction
  • F19.182 Other psychoactive substance abuse with psychoactive substance-induced sleep disorder
  • F19.188 Other psychoactive substance abuse with other psychoactive substance-induced disorder
  • F19.19 Other psychoactive substance abuse with unspecified psychoactive substance-induced disorder
  • F19.2 Other psychoactive substance dependence
  • F19.20 Other psychoactive substance dependence, uncomplicated
  • F19.21 Other psychoactive substance dependence, in remission
  • F19.22 Other psychoactive substance dependence with intoxication
  • F19.220 Other psychoactive substance dependence with intoxication, uncomplicated
  • F19.221 Other psychoactive substance dependence with intoxication delirium
  • F19.222 Other psychoactive substance dependence with intoxication with perceptual disturbance
  • F19.229 Other psychoactive substance dependence with intoxication, unspecified
  • F19.23 Other psychoactive substance dependence with withdrawal
  • F19.230 Other psychoactive substance dependence with withdrawal, uncomplicated
  • F19.231 Other psychoactive substance dependence with withdrawal delirium
  • F19.232 Other psychoactive substance dependence with withdrawal with perceptual disturbance
  • F19.239 Other psychoactive substance dependence with withdrawal, unspecified
  • F19.24 Other psychoactive substance dependence with psychoactive substance-induced mood disorder
  • F19.25 Other psychoactive substance dependence with psychoactive substance-induced psychotic disorder
  • F19.250 Other psychoactive substance dependence with psychoactive substance-induced psychotic disorder with delusions
  • F19.251 Other psychoactive substance dependence with psychoactive substance-induced psychotic disorder with hallucinations
  • F19.259 Other psychoactive substance dependence with psychoactive substance-induced psychotic disorder, unspecified
  • F19.26 Other psychoactive substance dependence with psychoactive substance-induced persisting amnestic disorder
  • F19.27 Other psychoactive substance dependence with psychoactive substance-induced persisting dementia
  • F19.28 Other psychoactive substance dependence with other psychoactive substance-induced disorders
  • F19.280 Other psychoactive substance dependence with psychoactive substance-induced anxiety disorder
  • F19.281 Other psychoactive substance dependence with psychoactive substance-induced sexual dysfunction
  • F19.282 Other psychoactive substance dependence with psychoactive substance-induced sleep disorder
  • F19.288 Other psychoactive substance dependence with other psychoactive substance-induced disorder
  • F19.29 Other psychoactive substance dependence with unspecified psychoactive substance-induced disorder
  • F19.9 Other psychoactive substance use, unspecified
  • F19.90 Other psychoactive substance use, unspecified, uncomplicated
  • F19.91 Other psychoactive substance use, unspecified, in remission
  • F19.92 Other psychoactive substance use, unspecified with intoxication
  • F19.920 Other psychoactive substance use, unspecified with intoxication, uncomplicated
  • F19.921 Other psychoactive substance use, unspecified with intoxication with delirium
  • F19.922 Other psychoactive substance use, unspecified with intoxication with perceptual disturbance
  • F19.929 Other psychoactive substance use, unspecified with intoxication, unspecified
  • F19.93 Other psychoactive substance use, unspecified with withdrawal
  • F19.930 Other psychoactive substance use, unspecified with withdrawal, uncomplicated
  • F19.931 Other psychoactive substance use, unspecified with withdrawal delirium
  • F19.932 Other psychoactive substance use, unspecified with withdrawal with perceptual disturbance
  • F19.939 Other psychoactive substance use, unspecified with withdrawal, unspecified
  • F19.94 Other psychoactive substance use, unspecified with psychoactive substance-induced mood disorder
  • F19.95 Other psychoactive substance use, unspecified with psychoactive substance-induced psychotic disorder
  • F19.950 Other psychoactive substance use, unspecified with psychoactive substance-induced psychotic disorder with delusions
  • F19.951 Other psychoactive substance use, unspecified with psychoactive substance-induced psychotic disorder with hallucinations
  • F19.959 Other psychoactive substance use, unspecified with psychoactive substance-induced psychotic disorder, unspecified
  • F19.96 Other psychoactive substance use, unspecified with psychoactive substance-induced persisting amnestic disorder
  • F19.97 Other psychoactive substance use, unspecified with psychoactive substance-induced persisting dementia
  • F19.98 Other psychoactive substance use, unspecified with other psychoactive substance-induced disorders

ICD-10 Code F19 is categorized under "mental and behavioral disorders due to psychoactive substance use" and specifically refers to "other psychoactive substance use, unspecified." This code is part of a broader category that addresses disorders related to the use of psychoactive substances, including but not limited to alcohol, opioids, cannabis, sedatives, cocaine, and other stimulants in combination with each other.


The designation of "unspecified" means that the documentation does not specify the type of psychoactive substance causing the disorder. This could be used in situations where a detailed assessment has not been completed, or the specific substance is unknown but its use is evident from the patient's behavior or self-report. It's important to note that more specific codes should be used if the substance being used is known, as this can impact treatment approaches and insurance coverage.


1. Documenting use

When documenting the use of F19, ensure that the patient's record clearly reflects the reasons for choosing an unspecified code, including any efforts made to determine the specific substance involved. This may be important for insurance audits or when transferring care.


2. Billing and insurance claims

When using F19 for billing purposes, it's crucial to check with the patient's insurance provider regarding coverage for treatment related to unspecified psychoactive substance use. Some insurers may require more specific diagnoses for reimbursement or may cover treatments under certain conditions. 


3. Ethical considerations

Given the potential implications of a diagnosis related to substance use, it's important to approach documentation and billing with sensitivity and adherence to confidentiality regulations. Providers should ensure that their diagnostic assessments prioritize patient welfare while balancing accurate medical recordkeeping, as stigmatization can impact both treatment outcomes and the patient's willingness to seek future care.


4. Follow-up and reassessment

For patients diagnosed with F19, regular reassessment is important to identify any changes in their condition, including the identification of specific substances being used. This can lead to more targeted treatment approaches and may necessitate updating the diagnosis code in their record and subsequent billing codes.


5. Coordination with insurance companies

Establish a clear line of communication with insurance companies regarding the use of unspecified codes like F19. Some insurers may require additional documentation or justification for the use of such codes.


Sources


  • "ICD-10 Code for Other psychoactive substance related disorders- F19- Codify by AAPC". Codify By AAPC. American Academy of Professional Coders, n.d., https://www.aapc.com/codes/icd-10-codes/F19?srsltid=AfmBOorSaHafzBY4EjSx8zy0QhKnZvMpb2EafMyKTwG8hxPnLRC7ww2C. Accessed 27 Jan 2025.

F18F20

Everything you need in one EHR